TIRZEPATIDE, TIRZEPATIDE, Placebo to match LY3298176, TIRZEPATIDE, IOHEXOL , TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE
I8F-MC-GPIG
Phase 2 small_molecule active
Quick answer
TIRZEPATIDE, TIRZEPATIDE, Placebo to match LY3298176, TIRZEPATIDE, IOHEXOL , TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE for Chronic Kidney Disease, CKD, Obesity, Overweight, T2D, Type 2 Diabetes is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Chronic Kidney Disease, CKD, Obesity, Overweight, T2D, Type 2 Diabetes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active